Key result
Type 2 diabetes mellitus is a risk factor for short-term poor prognosis, including all-cause death and stroke at one month, in patients with symptomatic severe aortic stenosis after TAVR.
Why the study?
The impact of type 2 diabetes mellitus on clinical outcomes and perioperative complications after TAVR in patients with aortic stenosis is not clear.
Does the presence of T2DM worsen the composite of all-cause death and stroke at one month in patients with symptomatic severe AS undergoing TAVR?
Observational
Does the presence of T2DM worsen the composite of all-cause death and stroke at one month in patients with symptomatic severe AS undergoing TAVR?
Answers are grounded in this paper and cite their sources.
Type 2 diabetes mellitus is associated with worse short-term clinical outcomes, including death and stroke at 1 month, in patients undergoing TAVR for severe aortic stenosis.
OBJECTIVES: Type 2 diabetes (T2DM) is a common comorbidity in patients with degenerative aortic stenosis (AS).As a key item of the American Society of Thoracic Surgeons (STS) score, it has a vital impact on the clinical prognosis of traditional thoracic surgery. T2DM has an adverse effect on the morbidity and mortality of cardiovascular diseases. At the same time, studies have shown that T2DM are associated with myocardial hypertrophy and remodeling, decreased left ventricular function, and worsening heart failure symptoms in the AS patients. Transcatheter aortic valve replacement (TAVR) as an interventional method to replace the aortic valve has better safety for middle and high risk patients in surgery, but the impact of T2DM on the clinical outcome of TAVR in AS patients is not clear.By analyzing the clinical and image characteristics of patients with AS and T2DM who received TAVR treatment, so as to explore the effect of T2DM on the perioperative complications and prognosis of TAVR. The primary end point was defined as a composite event consisting of all-cause death and stroke one month after surgery, and the secondary end point was defined as TAVR-related complications immediately after surgery and one month after surgery.The preoperative clinical data, cardiac ultrasound data, CT data, postoperative medication and the incidence of each endpoint event were compared between the 2 groups.The predictive model of adverse events was constructed by single factor and multivariate logistic regression. CONCLUSIONS: T2DM is a risk factor for short-term poor prognosis in patients with symptomatic severe AS after TAVR treatment. T2DM should play an important role in the future construction of the TAVR surgical risk assessment system, but the conclusions still need to be further verified by long-term follow-up of large-scale clinical studies.
No takes yet. Share an insight, caveat, or question.
Su et al. (2022) conducted an observational in Severe aortic stenosis. Type 2 diabetes mellitus vs. No type 2 diabetes mellitus was evaluated on Composite of all-cause death and stroke one month after surgery (p=<0.05). Type 2 diabetes mellitus is a risk factor for short-term poor prognosis, including all-cause death and stroke at one month, in patients with symptomatic severe aortic stenosis after TAVR.
Synapse has enriched 10 related papers. Consider them for comparative context: